TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/2/25 16:47 | 12/13/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | King Rachel K. | MD | D | S | -37 | 9.02 | 0 | -4 | -22 | 15 | D | |||||||||||||||
6/14/24 16:07 | 6/12/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | King Rachel K. | MD | D | M.d | 0 | 0.00 | 0 | 7 | 54 | 19 | D | |||||||||||||||
6/13/23 16:46 | 6/10/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | King Rachel K. | MD | D | M.d | 0 | 0.00 | 0 | 3 | 34 | 12 | D | |||||||||||||||
6/21/22 20:46 | 6/17/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | King Rachel K. | MD | D | M.d | 0 | 0.00 | 0 | 1 | 8 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |